Literature DB >> 7917302

Analysis of the functional effects of a mutation in SOD1 associated with familial amyotrophic lateral sclerosis.

T Tsuda1, S Munthasser, P E Fraser, M E Percy, I Rainero, G Vaula, L Pinessi, L Bergamini, G Vignocchi, D R McLachlan.   

Abstract

Mutations in the Cu, Zn superoxide dismutase (SOD1) gene have been reported in some pedigrees with Familial Amyotrophic Lateral Sclerosis (FALS). We have investigated the functional and structural effects of a Gly-->Ser mutation at codon 41 of SOD1 in a pedigree with FALS and the topography of SOD1 expression in the mammalian CNS. These analyses show that the 41Gly-->Ser mutation causes a 27% reduction in Cu, Zn SOD activity. SOD1 is transcribed at high levels in rat motoneurons and four other types of neurons homologous to upper motoneurons that degenerate in human ALS. However, SOD1 is transcribed at lower levels in other types of neurons, such as cerebellar Purkinje cells, which are not usually involved significantly in human ALS. On the other hand, immunocytochemical studies indicate that most types of rat neurons contain similar levels of Cu, Zn SOD immunoreactive protein. Nevertheless, these results suggest that the essential feature causing this subtype of ALS is either a reduction in Cu, Zn SOD activity in cell types that presumably critically require Cu, Zn SOD for protection against oxidative damage or the fact that the mutation in SOD1 associated with FALS results in a novel gain of function that is particularly deleterious to those cell types expressing SOD1 at high levels.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7917302     DOI: 10.1016/0896-6273(94)90039-6

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  12 in total

Review 1.  Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis: correlation between genotype and clinical features.

Authors:  A Radunovíc; P N Leigh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-12       Impact factor: 10.154

Review 2.  Gene discovery in amyotrophic lateral sclerosis: implications for clinical management.

Authors:  Ammar Al-Chalabi; Leonard H van den Berg; Jan Veldink
Journal:  Nat Rev Neurol       Date:  2016-12-16       Impact factor: 42.937

Review 3.  Posttranslational modifications in Cu,Zn-superoxide dismutase and mutations associated with amyotrophic lateral sclerosis.

Authors:  Yoshiaki Furukawa; Thomas V O'Halloran
Journal:  Antioxid Redox Signal       Date:  2006 May-Jun       Impact factor: 8.401

4.  Defective daily temperature regulation in a mouse model of amyotrophic lateral sclerosis.

Authors:  Maurine C Braun; Alexandra Castillo-Ruiz; Premananda Indic; Dae Young Jung; Jason K Kim; Robert H Brown; Steven J Swoap; William J Schwartz
Journal:  Exp Neurol       Date:  2018-07-18       Impact factor: 5.330

5.  Molecular analyses of the Cu/Zn superoxide dismutase gene in patients with familial amyotrophic lateral sclerosis (ALS) in Japan.

Authors:  M Aoki; K Abe; Y Itoyama
Journal:  Cell Mol Neurobiol       Date:  1998-12       Impact factor: 5.046

6.  Evidence of neuronal oxidative damage in Alzheimer's disease.

Authors:  P F Good; P Werner; A Hsu; C W Olanow; D P Perl
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

Review 7.  Familial amyotrophic lateral sclerosis/motor neurone disease (FALS): a review of current developments.

Authors:  J de Belleroche; R Orrell; A King
Journal:  J Med Genet       Date:  1995-11       Impact factor: 6.318

Review 8.  NLRP3 Inflammasome in Neurological Diseases, from Functions to Therapies.

Authors:  Limin Song; Lei Pei; Shanglong Yao; Yan Wu; You Shang
Journal:  Front Cell Neurosci       Date:  2017-03-09       Impact factor: 5.505

Review 9.  Copper Homeostasis as a Therapeutic Target in Amyotrophic Lateral Sclerosis with SOD1 Mutations.

Authors:  Eiichi Tokuda; Yoshiaki Furukawa
Journal:  Int J Mol Sci       Date:  2016-04-28       Impact factor: 5.923

Review 10.  Skeletal Muscle Satellite Cells, Mitochondria, and MicroRNAs: Their Involvement in the Pathogenesis of ALS.

Authors:  Stavroula Tsitkanou; Paul A Della Gatta; Aaron P Russell
Journal:  Front Physiol       Date:  2016-09-13       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.